Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Downgrades Arvinas to Neutral

Guggenheim Downgrades Arvinas to Neutral

Guggenheim analyst Michael Schmidt downgrades Arvinas (NASDAQ:ARVN) from Buy to Neutral.

byBenzinga Newsdesk

January 12, 2023

1 minute read

Guggenheim analyst Michael Schmidt downgrades Arvinas (NASDAQ:ARVN) from Buy to Neutral.

CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday

By Lisa Levin

November 28, 12:18 PM

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

AVXL

Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners – Read For How Much

By Vandana Singh

July 7, 10:45 AM

SD Biosensor Inc (SDB) and SJL Partners LLC have agreed to acquire Meridian Bioscience Inc (NASDAQ:VIVO) in an all-cash transaction valued…

VIVO

Cowen & Co. Downgrades Tricida to Market Perform

By Benzinga Newsdesk

October 24, 3:36 PM

Cowen & Co. analyst Phil Nadeau downgrades Tricida (NASDAQ:TCDA) from Outperform to Market Perform.

TCDA

Badger Meter: Q2 Earnings Insights

By Benzinga Insights

July 20, 10:02 AM

Badger Meter (NYSE:BMI) reported its Q2 earnings results on Wednesday, July 20, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

BMI

Guggenheim Downgrades Arvinas to Neutral

Related Posts

CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday

Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners – Read For How Much

Cowen & Co. Downgrades Tricida to Market Perform

Badger Meter: Q2 Earnings Insights